Uxin Limited (UXIN) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UXIN SEC filings page.
Uxin Limited (UXIN) reported $463.3M in revenue for fiscal year 2025, up 143.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025’s sharp revenue rebound improved transaction economics, but persistent cash absorption shows growth still requires external financing.
Gross margin rose from1.2% in FY2023 to6.7% in FY2025, showing better economics per transaction. Yet operating margin was still-5.4% in FY2025, so the improvement is not yet covering the operating structure.
FY2025 operating cash flow was
Current ratio recovered from 0.3x in FY2024 to 0.8x in FY2025, but remained below full coverage of current obligations. The reported liquidity comparison equaled 2 months of latest annual operating outflow, underscoring that financing—not operations—was supplying cash.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Uxin Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Uxin Limited has an operating margin of -5.4%, meaning the company loses $5 on every $100 of revenue. This results in a profitability score of 29/100. This is up from -22.7% the prior year.
Uxin Limited's revenue surged 143.3% year-over-year to $463.3M, reflecting rapid business expansion. This strong growth earns a score of 86/100.
Not available for Uxin Limited, and counted as zero in the overall score.
Uxin Limited's current ratio of 0.76 is below the typical benchmark, resulting in a score of 10/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Uxin Limited's operations used $72.1M of cash, and capex of $3.1M added to the outflow, for a free cash flow shortfall of $75.2M. This results in a cash flow score of 9/100.
Uxin Limited scores -10.11, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($222.2M) relative to total liabilities ($330.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Uxin Limited passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
Uxin Limited reported a net loss of $37.5M while operations used $72.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Uxin Limited reported an operating loss of $24.8M against $13.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Uxin Limited held $11.9M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
UXIN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
UXIN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K | Q4'2410-K | Q1'2410-K | Q1'2310-K | Q1'2210-K | Q3'2110-Q | Q1'2110-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $345.9M+29.3% | $285.3M | $267.4M | $289.2M+176.4% | $104.6M-47.0% | $197.4M+4.8% | $205.9M | $188.3M-49.6% |
| Current Assets | $106.4M+128.8% | $62.5M | $46.5M | $31.4M-23.6% | $41.0M-70.3% | $137.9M+8.5% | $146.1M | $127.1M-59.8% |
| Cash & Equivalents | $11.9M+245.1% | $9.5M | $3.4M | $3.2M-76.1% | $13.5M-33.2% | $20.2M-31.3% | $33.6M | $29.4M-39.2% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $78.0M+174.6% | $39.0M | $28.4M | $15.3M-5.2% | $16.1M-76.0% | $67.2M+533.1% | $45.3M | $10.6M+628.5% |
| Accounts Receivable | $660K+16.0% | $502K | $569K | $289K+151.3% | $115K-12.2% | $131K-65.1% | $515K | $375K-58.5% |
| Long-Term Investments | $0 | $0 | $0 | $38.7M-8.0% | $42.0M-7.7% | $45.5M+3.5% | $44.8M | $44.0M+12.6% |
| Total Liabilities | $330.8M+11.5% | $282.6M | $296.6M | $309.0M+6.5% | $290.0M-33.4% | $435.6M-11.6% | $707.6M | $492.9M-30.1% |
| Current Liabilities | $139.7M+33.8% | $90.7M | $104.4M | $122.6M+39.4% | $87.9M-57.1% | $204.9M+17.0% | $485.7M | $175.1M-59.7% |
| Non-Current Liabilities | $191.1M-0.6% | $191.9M | $192.2M | $186.4M+84.9% | $100.8M-31.7% | $147.7M-53.5% | $221.9M | $317.8M+17.5% |
| Long-Term Debt | N/A | N/A | $7.4M | N/A | $42.5M | N/A | $36.2M | N/A |
| Total Equity | -$33.0M+34.5% | -$39.8M | -$50.4M | -$40.6M+78.1% | -$185.4M+22.2% | -$238.2M+21.8% | -$501.7M | -$304.6M+8.0% |
| Retained Earnings | -$2.8B-5.9% | -$2.8B | -$2.7B | -$2.7B-8.8% | -$2.5B+2.6% | -$2.5B-4.3% | -$2.7B | -$2.4B-11.0% |
Not reported in any period shown, so not listed: Goodwill.
UXIN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
UXIN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$33.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Uxin Limited UXIN | FY2025 | $463.3M | -$37.5M | -8.1% | $222.2M | 24/100 |
| Camping World Holdings, Inc. CWH | FY2025 | $6.4B | -$105.6M | -1.7% | $287.9M | 29/100 |
| Kingsway Financial Services, Inc. KFS | FY2025 | $135.0M | -$10K | 0.0% | $306.6M | 26/100 |
| ACV Auctions Inc. ACVA | FY2025 | $759.6M | -$66.1M | -8.7% | $1.8B | 48/100 |
| Mister Car Wash, Inc. MCW | FY2025 | $1.1B | $103.1M | 9.8% | $2.3B | 38/100 |
| SunCar Technology Group Inc. SDA | FY2024 | $441.9M | -$64.5M | -14.6% | $30.8M | 30/100 |
Where Uxin Limited Ranks
Frequently Asked Questions
What is Uxin Limited's annual revenue?
Uxin Limited (UXIN) reported $463.3M in total revenue for fiscal year 2025. This represents a 143.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Uxin Limited's revenue growing?
Uxin Limited (UXIN) revenue grew by 143.3% year-over-year, from $190.4M to $463.3M in fiscal year 2025.
Is Uxin Limited profitable?
No, Uxin Limited (UXIN) reported a net income of -$37.5M in fiscal year 2025, with a net profit margin of -8.1%.
What is Uxin Limited's EBITDA?
Uxin Limited (UXIN) had EBITDA of -$15.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Uxin Limited's gross margin?
Uxin Limited (UXIN) had a gross margin of 6.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Uxin Limited's operating margin?
Uxin Limited (UXIN) had an operating margin of -5.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Uxin Limited's net profit margin?
Uxin Limited (UXIN) had a net profit margin of -8.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Uxin Limited's free cash flow?
Uxin Limited (UXIN) recorded an outflow of $75.2M in free cash flow during fiscal year 2025. This represents a -97.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Uxin Limited's operating cash flow?
Uxin Limited (UXIN) recorded an outflow of $72.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Uxin Limited's total assets?
Uxin Limited (UXIN) had $345.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Uxin Limited's capital expenditures?
Uxin Limited (UXIN) invested $3.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Uxin Limited spend on research and development?
Uxin Limited (UXIN) invested $1.8M in research and development during fiscal year 2025.
What is Uxin Limited's current ratio?
Uxin Limited (UXIN) had a current ratio of 0.76 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Uxin Limited's return on assets (ROA)?
Uxin Limited (UXIN) had a return on assets of -10.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Uxin Limited's P/E ratio?
Uxin Limited (UXIN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $222.2M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Uxin Limited's price-to-sales ratio?
Uxin Limited (UXIN) trades at 0.5x sales, its market capitalization divided by revenue of $463.3M revenue, FY2025. The market capitalization is $222.2M as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Uxin Limited's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Uxin Limited (UXIN) held $11.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $72.1M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Uxin Limited's debt-to-equity ratio negative or not reported?
Uxin Limited (UXIN) has negative shareholder equity of -$33.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Uxin Limited's Altman Z-Score?
Uxin Limited (UXIN) has an Altman Z-Score of -10.11, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Uxin Limited's Piotroski F-Score?
Uxin Limited (UXIN) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Uxin Limited's earnings high quality?
Uxin Limited (UXIN) reported a net loss of $37.5M while operations used $72.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Uxin Limited cover its interest payments?
Uxin Limited (UXIN) reported an operating loss of $24.8M against $13.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Uxin Limited?
Uxin Limited (UXIN) scores 24 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.